Achieve Life Sciences, Inc. (ACHV)
4.84
+0.14
(+2.98%)
USD |
NASDAQ |
Dec 31, 12:56
Achieve Life Sciences EPS Diluted (Quarterly): -0.2831 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| StimCell Energetics, Inc. | -0.0131 |
| Venus Concept, Inc. | -12.14 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.44M |
| Total Expenses (Quarterly) | 14.44M |
| Enterprise Value | 212.04M |
| Earnings Yield | -28.47% |
| Normalized Earnings Yield | -28.17 |